Founded in 2018, Clara Biotech’s team of leading scientific researchers from across the country are actively dedicating their 50+ years of combined experience to address the critical manufacturing challenges keeping exosome solutions from reaching the patients who need them most.
Jim West, MS
Chief Executive Officer
Jim West has been actively working on medical device product and company development since earning his MS in biomedical product development from KU (2011), and a Masters Certificate in Entrepreneurship from Nanyang Technological University in Singapore (2009) thanks to a grant from the Kauffman Foundation. He has worked in all areas of medical product development.
Mei He, PhD
Chief Science Officer
Dr. Mei He is a professor at the University of Florida. She received her PhD from the University of Alberta and postdoctoral training from UC Berkeley. Since 2015 she has served as a principal investigator and been leading a career in translational medicine involving cutting-edge microfluidic technology, 3D bioprinting, nano-biomaterials, and exosomes. In February 2019 she was published in Nature Biomedical Engineering detecting ovarian cancer through exosomal markers.
Tom Krol, PharmD
Chief Development Officer
Thomas Krol PharmD has a passion to bring new technologies to people who need them. He has worked in large pharma companies like Pfizer and Sanofi in both R&D and commercial roles and in start-ups. Tom also worked as Managing Director of the KBA. He has a B.S. in pharmacy from Ferris State University and PharmD from the University of Utah. He completed a residency at the University of Utah and a fellowship in drug development at the University of North Carolina.
From right to left:
Tom Krol, CDO
Nav Singh, Product Manager and Technical Lead
Curtis Yingling, Senior Scientist
Joy Hayden, Lab Manager
Jim West, CEO
Ben Smith, Sales
Mei He, PhD
Kelly Young, Exec. Assistant & Accounts